<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-108594-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Comprendre le r&#xF4;le de l&#x2019;interf&#xE9;ron de type 1 dans la r&#xE9;sistance &#xE0; l&#x2019;immunoth&#xE9;rapie du cancer</narrative>
   <narrative xml:lang="EN">Understanding the role of type 1 interferon in resistance to cancer immunotherapy</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Chemotherapy is the main form of treatment for cancer, but it cannot cure most types of cancer. Another form of treatment is immunotherapy, which aims to stimulate cells of the body&apos;s immune system (T cells) to kill cancer cells. Unfortunately, cancers may become resistant to T cells in the same way they learned to resist chemotherapy. This resistance is partly caused by a blood protein called interferon. 

This project aims to improve the effectiveness of cancer immunotherapy. Based on previous work, the research team will investigate the use of interferon inhibitors to treat cancer cells from patients with leukemia. This approach is expected to increase cure rates with immunotherapy in leukemia and many other forms of cancer. Moreover, the results of this study can open the path to the development of new and innovative cancer drugs based on interferon inhibition.

The project is led in Canada by the Sunnybrook Research Institute-University of Toronto in collaboration with the Weizmann Institute of Science (Israel), and Jilin University (China). 

This project was selected for funding through the third research competition of the Joint Canada-Israel Health Research Program, a partnership between IDRC, the Canadian Institutes of Health Research, the Israel Science Foundation, and the Azrieli Foundation.</narrative>
   <narrative xml:lang="FR">La chimioth&#xE9;rapie est la principale forme de traitement du cancer, mais elle ne peut pas gu&#xE9;rir la plupart des types de cancers. L&#x2019;immunoth&#xE9;rapie constitue une autre forme de traitement qui vise &#xE0; stimuler les cellules du syst&#xE8;me immunitaire (lymphocytes T) afin de tuer les cellules canc&#xE9;reuses. Malheureusement, les cancers peuvent devenir r&#xE9;sistants aux lymphocytes T de la m&#xEA;me fa&#xE7;on qu&#x2019;ils ont d&#xE9;velopp&#xE9;s une r&#xE9;sistance &#xE0; la chimioth&#xE9;rapie. Cette r&#xE9;sistance est partiellement caus&#xE9;e par une prot&#xE9;ine sanguine appel&#xE9; &#xAB; interferon &#xBB;. 

Ce projet vise &#xE0; am&#xE9;liorer l&#x2019;efficacit&#xE9; de l&#x2019;immunoth&#xE9;rapie anticanc&#xE9;reuse. En s&#x2019;appuyant sur des &#xE9;tudes pr&#xE9;c&#xE9;dentes, l&#x2019;&#xE9;quipe de recherche examinera l&#x2019;utilisation des inhibiteurs d&#x2019;interferon afin de traiter les cellules canc&#xE9;reuses chez les patients atteints de la leuc&#xE9;mie. On s&#x2019;attend &#xE0; ce que cette approche utilisant l&#x2019;immunoth&#xE9;rapie augmente les taux de gu&#xE9;rison de la leuc&#xE9;mie et bon nombre d&#x2019;autres formes de cancer. De plus, les r&#xE9;sultats de cette &#xE9;tude peuvent ouvrir la voie &#xE0; l&#x2019;&#xE9;laboration de nouveaux m&#xE9;dicaments anticanc&#xE9;reux novateurs en s&#x2019;appuyant sur l&#x2019;inhibition de l&#x2019;interf&#xE9;ron.

Ce projet est dirig&#xE9; au Canada par le Sunnybrook Research Institute de l&#x2019;Universit&#xE9; de Toronto, en collaboration avec le Weizmann Institute of Science (Isra&#xEB;l) et l&#x2019;Universit&#xE9; de Jilin (Chine). 

Il a &#xE9;t&#xE9; retenu aux fins de financement au cours du troisi&#xE8;me concours de recherche du Programme conjoint canado-isra&#xE9;lien de recherche en sant&#xE9;, un partenariat entre le CRDI, les Instituts de recherche en sant&#xE9; du Canada, l&#x2019;Israel Science Foundation et l&#x2019;Azrieli Foundation.</narrative>
  </description>
  <participating-org role="1" type="24">
   <narrative xml:lang="EN">Azrieli Foundation</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="21">
   <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
  </participating-org>
  <participating-org role="4" type="21">
   <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2017-11-01" type="2"></activity-date>
  <activity-date iso-date="2021-11-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="1" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Autre</narrative>
   <narrative xml:lang="EN">Other</narrative>
  </sector>
  <sector code="12182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-11-27"></transaction-date>
   <value currency="CAD" value-date="2017-11-27">166667</value>
   <provider-org>
    <narrative xml:lang="EN">Azrieli Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-11-27"></transaction-date>
   <value currency="CAD" value-date="2017-11-27">503333</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-11-27"></transaction-date>
   <value currency="CAD" value-date="2017-11-27">27777</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-11-27"></transaction-date>
   <value currency="CAD" value-date="2017-11-27">83889</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-05-01"></transaction-date>
   <value currency="CAD" value-date="2018-05-01">27777</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-05-01"></transaction-date>
   <value currency="CAD" value-date="2018-05-01">83888</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-11-02"></transaction-date>
   <value currency="CAD" value-date="2018-11-02">27777</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-11-02"></transaction-date>
   <value currency="CAD" value-date="2018-11-02">83889</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-05-28"></transaction-date>
   <value currency="CAD" value-date="2019-05-28">27777</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-05-28"></transaction-date>
   <value currency="CAD" value-date="2019-05-28">83888</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-11-01"></transaction-date>
   <value currency="CAD" value-date="2019-11-01">27777</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-11-01"></transaction-date>
   <value currency="CAD" value-date="2019-11-01">83889</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-138889</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-419443</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">138889</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">419443</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-04"></transaction-date>
   <value currency="CAD" value-date="2020-05-04">19444</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-04"></transaction-date>
   <value currency="CAD" value-date="2020-05-04">58722</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="CAD" value-date="2020-05-31">-19444</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="CAD" value-date="2020-05-31">-58722</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="CAD" value-date="2020-05-31">19444</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-05-31"></transaction-date>
   <value currency="CAD" value-date="2020-05-31">58722</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Sunnybrook Research Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
